Butanediamide, N4-[5-[[4-[[5-(acetylhydroxyamino)pentyl]amino]-1,4-dioxobutyl]hydroxyamino]pentyl]-N1-(5-aminopentyl)-N1-hydroxy-, methanesulfonate (1:1) N4-[5-[[4-[[5-(乙酰羟基氨基)戊基]氨基]-1,4-二氧代丁基]羟基氨基]戊基]-N1-(5-氨基戊基)-N1-羟基-丁二酰胺甲磺酸盐
CAS 138-14-7 MFCD00058605
化学结构图
SMILES: CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN.CS(=O)(=O)O
化学属性
| Mol. Formula | C26H52N6O11S |
|---|---|
| Mol. Weight | 657 |
| Melting Point | 145-149 |
别名和识别编码
| Chemical Name | Butanediamide, N4-[5-[[4-[[5-(acetylhydroxyamino)pentyl]amino]-1,4-dioxobutyl]hydroxyamino]pentyl]-N1-(5-aminopentyl)-N1-hydroxy-, methanesulfonate (1:1) |
|---|---|
| MDL Number | MFCD00058605 |
| CAS Number | 138-14-7 |
| Synonym | DFOM DFOM Deferoxamine methanesulfonate salt Desferrioxamine mesylate salt Deferoxamine Methanesulfonate Deferoxamine mesilate Deferoxamine mesylate Deferoxamine mesylate salt Deferoxamine methanesulfonate Deferoxamine methanesulfonate salt Desferal Desferal mesylate Desferal methanesulfonate Desferrioxamine B mesylate Desferrioxamine B methanesulfonate Desferrioxamine mesylate salt Desferrioxamine methanesulfonate 甲磺酸去铁胺; 甲磺酸去铁敏; 甲磺酸除铁灵 |
| PubChem Substance ID | 62881 |
| EC Number | 205-314-3 |
| Chemical Name Translation | N4-[5-[[4-[[5-(乙酰羟基氨基)戊基]氨基]-1,4-二氧代丁基]羟基氨基]戊基]-N1-(5-氨基戊基)-N1-羟基-丁二酰胺甲磺酸盐 |
| Reaxys-RN | 4122177 |
| Merck Number | 2860 |
| InChIKey | IDDIJAWJANBQLJ-UHFFFAOYSA-N |
| Wiswesser Line Notation | Z5NQV2VM5NQV2VM5NQV1 &WSQ1 |
| Beilstein Registry Number | 4122177 |
| LabNetwork Molecule ID | LN00223573 |
| InChI | InChI=1S/C25H48N6O8.CH4O3S/c1-21(32)29(37)18-9-3-6-16-27-22(33)12-14-25(36)31(39)20-10-4-7-17-28-23(34)11-13-24(35)30(38)19-8-2-5-15-26;1-5(2,3)4/h37-39H,2-20,26H2,1H3,(H,27,33)(H,28,34);1H3,(H,2,3,4) |
信息真实价格透明
资金保障
专业采购外包团队在线服务
信息真实价格透明
资金保障
专业采购外包团队在线服务
品牌质保精细包装
现货库存
一流品牌服务
分类
- {SNA} Antioxidants and Cytoprotectants, Bioactive Small Molecules, Cancer Metabolism, Cell Signaling and Neuroscience, Cell Stress, D-DIF, HIF Prolyl-Hydroxylase Inhibitors, Inhibitors of Aerobic Glycolysis (the Warburg Effect), Nitric Oxide and Cell Stress, 有氧糖酵解（Warburg效应）, 癌症研究,
安全信息
- S24/25 Avoid contact with skin and eyes 避免皮肤和眼睛接触；
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Oral SPECIES OBSERVED : Rodent - rat DOSE/DURATION : 17300 mg/kg TOXIC EFFECTS : Details of toxic effects not reported other than lethal dose value REFERENCE : NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) Volume(issue)/page/year: 6,496,1982
TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Parenteral SPECIES OBSERVED : Human - man DOSE/DURATION : 16 gm/kg/34W-I TOXIC EFFECTS : Cardiac - pericarditis Gastrointestinal - ulceration or bleeding from small intestine Blood - other changes REFERENCE : AJKDDP American Journal of Kidney Diseases. (Grune & Stratton, Inc., Jou
TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Subcutaneous SPECIES OBSERVED : Human - woman DOSE/DURATION : 150 mg/kg/4D-I TOXIC EFFECTS : Gastrointestinal - hypermotility, diarrhea Gastrointestinal - nausea or vomiting REFERENCE : BMJOAE British Medical Journal. (British Medical Assoc., BMA House, Tavistock Sq., London WC1H 9JR, UK) V.1- 1857- Volume(issue)/page/year: 291,448,1985
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Subcutaneous SPECIES OBSERVED : Rodent - rat DOSE/DURATION : 5500 mg/kg TOXIC EFFECTS : Details of toxic effects not reported other than lethal dose value REFERENCE : NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) Volume(issue)/page/year: 6,496,1982
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Intravenous SPECIES OBSERVED : Rodent - mouse DOSE/DURATION : 273 mg/kg TOXIC EFFECTS : Details of toxic effects not reported othe
GHS Symbol
- P262 Do not get in eyes, on skin, or on clothing. 不要接触眼睛，皮肤或衣服。
京ICP备2020036287号